Clinical trial
Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory…
NCT00113295 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00113295 |
|---|---|
| Title | Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder |
| Official title | Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Continued Paroxetine CR, Quetiapine, Placebo |
| Enrollment | 50 |
| Start date | Feb 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jun 8, 2005 |
| Last update posted | Apr 23, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: